Nova Leah is a world leader in the provision of cybersecurity risk management solutions for medical device manufacturers and healthcare providers. Nova Leah’s flagship product, SelectEvidence™, is a multi-award-winning cybersecurity risk management solution used by medical device manufacturers worldwide. Built with powerful AI and automation technologies, SelectEvidence™ continuously monitors device vulnerabilities and identifies appropriate mitigations, while generating live regulatory reports.
In 2023, Nova Leah launched SelectEvaluateⓇ, an AI-powered platform that is transforming medical device third party risk management and cybersecurity monitoring across the healthcare supply chain. SelectEvaluateⓇ better connects medical device manufacturers with healthcare providers, while allowing healthcare providers to streamline their entire third-party risk management process, reducing the TPRM timeline from up to 12 weeks to less than 24 hours.
Contact Info:
Joseph (Joe) Madden
Vice President of Sales
857-289-4891
Joe.Madden@NovaLeah.com
www.NovaLeah.com
Categories:
Security, Apps & Cloud
